Journal article
Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma
Abstract
The plasma cell proliferative index (PCPI), determined by a slide technique or by flow cytometry, detects cells in the S phase of the cell cycle and is a useful prognostic tool in patients with plasma cell disorders such as multiple myeloma and amyloidosis. We conducted a retrospective review analyzing the prognostic effect of PCPI in 306 patients with smoldering multiple myeloma (SMM). Seventy-nine (26%) patients had an elevated PCPI (>0.5). …
Authors
Aljama MA; Sidiqi MH; Lakshman A; Dispenzieri A; Jevremovic D; Gertz MA; Lacy MQ; Buadi FK; Dingli D; Muchtar E
Journal
Blood Advances, Vol. 2, No. 22, pp. 3149–3154
Publisher
American Society of Hematology
Publication Date
November 27, 2018
DOI
10.1182/bloodadvances.2018024794
ISSN
2473-9529